Thanks Weird. Point well made. Just want to kick someone when...

First 103 Last

Share
Profile

Follow
Cotton2103

1,359 Posts.

366

25/06/24

12:08

Post #: 74476715
Share

Originally posted by werdplaya58: ↑

I think there is a lot that is commercial in confidence between A2M and Synlait.

For instance, late last year pricing became a part of the dispute between the two parties. Details like pricing, minimum volumes, etc have always been confidential in the A2M-Synlait supply agreement so there is not a whole lot either party can say other than what is in dispute.

The bigger issue here is that there are not many things A2M can say about the situation without needlessly telegraphing their intentions. I can't think of much they could say about the situation that doesn't just reveal their hand prematurely or box them into a course they might not want to commit to yet.

They can't really be expected to commit to a specific course of action about Synlait when the situation is changing rapidly and Bright Dairy have also not revealed their end game either. It is not exactly like Bright is saying much publicly about the situation either.

I don't think A2M is being overly 'nice' to Synlait. We've already terminated their exclusive supply rights, disputed their pricing, shifted business to their next door neighbors Yili, and are now holding them hostage to insolvency. That's more than enough to get them booted off the Christmas card list

Expand

Thanks Weird. Point well made. Just want to kick someone when they are down I guess.

Last edited by Cotton2103: 25/06/24

A2M Price at posting: $6.50 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

There are more pages in this discussion • 72 more messages in this thread...

First 103 Last

Add A2M (ASX) to my watchlist

(20min delay)
Last $6.82		Change 0.010(0.15%)		Mkt cap ! $4.930B

Open	High	Low	Value	Volume
$6.80	$6.92	$6.75	$12.34M	1.813M

Buyers (Bids)

No.	Vol.	Price($)
2	3893	$6.81

Sellers (Offers)

Price($)	Vol.	No.
$6.83	17044	5

View Market Depth

No.	Vol.	Price($)
1	14	6.800
3	8610	6.790
2	17226	6.780
2	10279	6.770
1	2504	6.760

Price($)	Vol.	No.
6.830	9758	3
6.840	8610	3
6.850	6062	2
6.860	5330	2
6.870	20000	1

Last trade - 16.10pm 10/07/2024 (20 minute delay)

A2M (ASX) Chart

Thanks Weird. Point well made. Just want to kick someone when...

Greentech finds lithium trend across 5.5 km at WA's Kobe South

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks Weird. Point well made. Just want to kick someone when...

Top Stories

Greentech finds lithium trend across 5.5 km at WA's Kobe South

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News